castlebiosciences.com Open in urlscan Pro
35.188.87.193  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to content

COVID-19 Response

Customer Service: 866-788-9007

PHYSICIAN LOGIN | CRF LOGIN

ORDER TEST




COVID-19 Response

ORDER TEST




Customer Service: 866-788-9007

PHYSICIAN LOGIN | CRF LOGIN

Customer Service: 866-788-9007

PHYSICIAN LOGIN | CRF LOGIN


 * CompanyMenu Toggle
   * About Us
   * Our History
   * Executive Management
   * Board of Directors
   * Licenses
   * Careers
   * Contact Us
 * ProductsMenu Toggle
   * Cutaneous Melanoma
   * DecisionDx®-Melanoma
   * myPath® Melanoma and DiffDx™-Melanoma
   * DecisionDx®-CMSeq
   * Cutaneous SCC
   * DecisionDx®-SCC
   * Uveal Melanoma
   * DecisionDx®-UM
   * DecisionDx®-UMSeq
   * DecisionDx®-PRAME
 * Research & DevelopmentMenu Toggle
   * Our Approach
 * InvestorsMenu Toggle
   * Overview
   * News
   * Events & Presentations
   * Stock Info
   * Financials
   * Corporate Governance
   * Resources
 * Scientific PublicationsMenu Toggle
   * DecisionDx®-Melanoma
   * DecisionDx® DiffDx™-Melanoma
   * DecisionDx®-SCC
   * DecisionDx®-UMSeq
 * ResourcesMenu Toggle
   * Healthcare Professionals
   * Login/Register
   * Order a Test
   * Patients
   * Overview of our Tests
   * Frequently Asked Questions
   * Insurance Coverage

 * LATEST NEWS: Castle Biosciences President and CEO Derek Maetzold Will Deliver
   Keynote Presentation During Arizona Bioscience Week




PROGNOSTIC AND DIAGNOSTIC TESTS THAT HELP PEOPLE LIVE

Innovation in prognostic and diagnostic tests for dermatologic cancers enabling
more accurate treatment plan decisions

Learn More



DECISIONDX®- OUR GENE EXPRESSION PROFILE (GEP) TESTS

Providing personalized, clinically actionable, tumor-specific genomic
information to enable more accurate treatment plan decisions

Prognostic Tests
DecisionDx-Melanoma
DecisionDx-SCC
DecisionDx-UM
Diagnostic Tests
myPath® Melanoma
DiffDx-Melanoma




A DEVELOPMENT PROGRAM FOCUSED ON DERMATOLOGIC CANCERS

Developing novel, clinically actionable, tumor-specific genomic tests for
improved decision-making and patient care

Learn More



INNOVATORS WITH A PROVEN TRACK RECORD OF SUCCESS

An experienced team with deep expertise in discovering, developing, and
commercializing diagnostic and prognostic tests

Learn More


 


CONNECT WITH US




COMPANY

 * About Us
 * Our History
 * Leadership
   * Executive Management
   * Board of Directors
 * Licenses
 * Careers
 * Contact Us




PRODUCTS

 * Cutaneous Melanoma
   * DecisionDx-Melanoma
   * myPath Melanoma and DiffDx-Melanoma
   * DecisionDx-CMSeq
 * Cutaneous SCC
   * DecisionDx-SCC
 * Uveal Melanoma
   * DecisionDx-UM
   * DecisionDx-UMSeq
   * DecisionDx-PRAME


RESEARCH & DEVELOPMENT

 * Our Approach


LATEST NEWS & PUBLICATIONS

 * Press Releases
 * Scientific Publications
 * Email Alerts


RESOURCES

 * Healthcare Professionals
   * Login/Register
   * Order A Test
 * Patients
   * Overview of our Tests
   * Frequently Asked Questions
   * Insurance Coverage

Copyright © 2021 Castle Biosciences, Inc. | All Rights Reserved

 * Privacy Policy
 * Terms of Use
 * Contact Us